Copeptin has been shown to predict incident stroke in diabetic patients undergoing haemodialysis [15], but its ability to predict incident stroke events in individuals with and without diabetes among the older general population has not yet been assessed. The gene discussed is AVP; the disease is diabetes mellitus.